November 2018 - First Report Managed Care
Department
Conference Insider
11/28/2018
The efficacy and safety of EyePoint Pharmaceuticals Yutiq (fluocinolone acetonide intravitreal implant) 0.18 mg 3-year micro-insert for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye was supported by...
The efficacy and safety of EyePoint Pharmaceuticals Yutiq (fluocinolone acetonide intravitreal implant) 0.18 mg 3-year micro-insert for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye was supported by...
The efficacy and safety of...
11/28/2018
First Report Managed Care
Conference Insider
11/28/2018
Currently, detecting Alzheimer disease (AD) is a challenge. However, a new, noninvasive imaging device—which examines the smallest veins in the back of the eye, including the red blood cells moving through the retina—can be used to detect...
Currently, detecting Alzheimer disease (AD) is a challenge. However, a new, noninvasive imaging device—which examines the smallest veins in the back of the eye, including the red blood cells moving through the retina—can be used to detect...
Currently, detecting Alzheimer...
11/28/2018
First Report Managed Care
Conference Insider
11/28/2018
According to a poster presented at the Annual Meeting of the American Academy of Ophthalmology, ocular inflammation and pain in patients following cataract surgery was effectively treated with KPI-121 1%.
According to a poster presented at the Annual Meeting of the American Academy of Ophthalmology, ocular inflammation and pain in patients following cataract surgery was effectively treated with KPI-121 1%.
According to a poster presented...
11/28/2018
First Report Managed Care
Conference Insider
11/28/2018
A team of researchers found that patients with health savings accounts (HSAs) who are on autoimmune drugs had a significantly higher risk for discontinuation, lower proportion of days covered, and lower monthly fill rates after implementation...
A team of researchers found that patients with health savings accounts (HSAs) who are on autoimmune drugs had a significantly higher risk for discontinuation, lower proportion of days covered, and lower monthly fill rates after implementation...
A team of researchers found that...
11/28/2018
First Report Managed Care
Conference Insider
11/28/2018
Despite the late timing of reports and less-than-transparent evaluation process, the Institute for Clinical and Economic Review (ICER) has potential to provide unbiased clinical and economic evaluations, according to a recent survey of...
Despite the late timing of reports and less-than-transparent evaluation process, the Institute for Clinical and Economic Review (ICER) has potential to provide unbiased clinical and economic evaluations, according to a recent survey of...
Despite the late timing of...
11/28/2018
First Report Managed Care
Conference Insider
11/28/2018
Manufacturers believe payers will begin to use the Institute for Clinical and Economic Review (ICER) assessments more frequently and that payers are also becoming more proactive by integrating ICER requirements into their evidence generation...
Manufacturers believe payers will begin to use the Institute for Clinical and Economic Review (ICER) assessments more frequently and that payers are also becoming more proactive by integrating ICER requirements into their evidence generation...
Manufacturers believe payers...
11/28/2018
First Report Managed Care
Conference Insider
11/28/2018
According to a recent study presented at AMCP Nexus 2018, providing transparent cost information to prescribers resulted in a positive impact on prescribing trends, and researchers found that prescribers were willing to make retroactive...
According to a recent study presented at AMCP Nexus 2018, providing transparent cost information to prescribers resulted in a positive impact on prescribing trends, and researchers found that prescribers were willing to make retroactive...
According to a recent study...
11/28/2018
First Report Managed Care
Conference Insider
11/28/2018
Despite their high price tag, CAR-T regimens were found to be cost-effective compared with other recently approved novel anticancer regimens, according to recent research presented at AMCP Nexus 2018.
Despite their high price tag, CAR-T regimens were found to be cost-effective compared with other recently approved novel anticancer regimens, according to recent research presented at AMCP Nexus 2018.
Despite their high price tag,...
11/28/2018
First Report Managed Care
Conference Insider
11/28/2018
According to the findings, where were presented at AMCP Nexus 2018, generic substitution (GS) and step-therapy (ST) were top concerns for payers, while manufacturer-sponsored drug coupons or copay cards (CB) and pricing transparency (PT)...
According to the findings, where were presented at AMCP Nexus 2018, generic substitution (GS) and step-therapy (ST) were top concerns for payers, while manufacturer-sponsored drug coupons or copay cards (CB) and pricing transparency (PT)...
According to the findings, where...
11/28/2018
First Report Managed Care
Department
11/28/2018
Outcomes-based contracting (OBC) is gaining traction as a tactic to reduce high drug costs, according to a recent study presented at AMCP Nexus 2018.
Outcomes-based contracting (OBC) is gaining traction as a tactic to reduce high drug costs, according to a recent study presented at AMCP Nexus 2018.
Outcomes-based contracting (OBC)...
11/28/2018
First Report Managed Care
